BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9487512)

  • 1. Drug delivery models transported to a new level.
    Edelman ER; Lovich M
    Nat Biotechnol; 1998 Feb; 16(2):136-7. PubMed ID: 9487512
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical antibody delivery systems produce sustained levels in mucosal tissue and blood.
    Kuo PY; Sherwood JK; Saltzman WM
    Nat Biotechnol; 1998 Feb; 16(2):163-7. PubMed ID: 9487523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term vaginal antibody delivery: delivery systems and biodistribution.
    Saltzman WM; Sherwood JK; Adams DR; Castle P; Haller P
    Biotechnol Bioeng; 2000 Feb; 67(3):253-64. PubMed ID: 10620255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research on intelligent controlled drug delivery with polymer].
    Zhang Z; Tang C; Chen H; Shan L; Wan C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):205-8, 224. PubMed ID: 16532842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular sustained drug delivery using implantable polymeric devices.
    Yasukawa T; Ogura Y; Sakurai E; Tabata Y; Kimura H
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2033-46. PubMed ID: 16263193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow-release delivery systems.
    Squire I; Lees K
    Practitioner; 1992 Nov; 236(1520):1088-91. PubMed ID: 1305755
    [No Abstract]   [Full Text] [Related]  

  • 7. Engineered polymers and polymeric systems in controlled drug delivery and targeting. Preface.
    Avgoustakis K
    Eur J Pharm Biopharm; 2009 Mar; 71(3):407-8. PubMed ID: 19150405
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of polymer membrane formation in sustained release drug delivery systems.
    McHugh AJ
    J Control Release; 2005 Dec; 109(1-3):211-21. PubMed ID: 16288815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioerodible polymers for ocular drug delivery.
    Deshpande AA; Heller J; Gurny R
    Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing new methods for the treatment of malignant brain tumours: local delivery of anti-neoplastic agents using biodegradable polymers.
    Olivi A; DiMeco F; Bohan E; Brem H
    Forum (Genova); 2000; 10(2):152-65. PubMed ID: 10875976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery: the heart of the matter.
    Putnam D
    Nat Mater; 2008 Nov; 7(11):836-7. PubMed ID: 18955993
    [No Abstract]   [Full Text] [Related]  

  • 12. In situ forming parenteral drug delivery systems: an overview.
    Packhaeuser CB; Schnieders J; Oster CG; Kissel T
    Eur J Pharm Biopharm; 2004 Sep; 58(2):445-55. PubMed ID: 15296966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of biomimetic systems in drug delivery.
    Venkatesh S; Byrne ME; Peppas NA; Hilt JZ
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1085-96. PubMed ID: 16296811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release using mesoporous materials containing gate-like scaffoldings.
    Aznar E; Martínez-Máñez R; Sancenón F
    Expert Opin Drug Deliv; 2009 Jun; 6(6):643-55. PubMed ID: 19519290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular engineering of dendritic polymers and their application as drug and gene delivery systems.
    Paleos CM; Tsiourvas D; Sideratou Z
    Mol Pharm; 2007; 4(2):169-88. PubMed ID: 17222053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions.
    Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA
    Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecularly imprinted materials as advanced excipients for drug delivery systems.
    Alvarez-Lorenzo C; Concheiro A
    Biotechnol Annu Rev; 2006; 12():225-68. PubMed ID: 17045196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pros and cons of polyelectrolyte capsules in drug delivery.
    De Geest BG; Sukhorukov GB; Möhwald H
    Expert Opin Drug Deliv; 2009 Jun; 6(6):613-24. PubMed ID: 19519288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.